Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 65 % of short-term debt in 2025; threshold 65 %.
-
Figures corrected NBB
Corrected annual account filed for 2022.
Financials
Financial year 2025
COLOPLAST BELGIUM from Beersel, company number BE0423051642, closed financial year 2025 with a result of € 5.4 million after tax. For that financial year COLOPLAST BELGIUM recorded revenue of € 58.2 million and equity of € 3.1 million. Compared with financial year 2024, the result moved from € 2.8 million to € 5.4 million. Profitable, and profit is growing. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on April 28, 2026.
€ 3.1 million
▼ 1% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 5.4 million
▲ 95% vs 2024
Profit after tax over the fiscal year.
€ 110,768
▲ € 109,446 vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 7 million paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
58.1
▲ 9.5 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 8.5 million
▲ 24% vs 2024
€ 147,000 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 16,634
▼ 38% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 106
▼ 97% vs 2024
Loans from banks and other lenders, long and short.
€ 3.9 million
▲ 1% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 33 days on average.
€ 2.8 million
▲ 58% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 45,735,468 | € 48,899,169 | € 51,548,623 | € 58,206,927 | ▲ 13% |
| Profit after taxes | € 2,685,572 | € 3,265,439 | € 2,792,401 | € 5,449,913 | ▲ 95% |
| Equity | € 3,038,615 | € 3,304,054 | € 3,096,455 | € 3,052,330 | ▼ 1% |
| Total debts | € 7,543,080 | € 8,621,817 | € 8,668,552 | € 13,767,923 | ▲ 59% |
| Cash | € 1,115 | € 1,321 | € 1,322 | € 110,768 | ▲ € 109,446 |
| Retained profit | € 1,340,300 | € 1,605,739 | € 1,398,140 | € 1,335,465 | ▼ 4% |
| Dividend | € 2,000,000 | € 3,000,000 | € 3,000,000 | € 7,000,000 | ▲ 133% |
| Bank debt | € 0 | € 0 | € 3,066 | € 106 | ▼ 97% |
| Balance sheet total | € 10,861,301 | € 12,037,506 | € 11,804,354 | € 16,826,822 | ▲ 43% |
| Employees (FTE) | 41.5 | 49 | 48.6 | 58.1 | ▲ 9.5 |
Key figures of COLOPLAST BELGIUM, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.
What happened to COLOPLAST BELGIUM?
What happened at COLOPLAST BELGIUM in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Anton Malling Mikkelsen stepped down as director. NBB
- Henrik Deneke stepped down as director. NBB
- Henning Reichardt stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 5.4 million (▲ 95% vs 2024). Source: NBB ↗
- Anton Malling Mikkelsen became a director. NBB
- Henrik Deneke became a director. NBB
- Henning Reichardt became a director. NBB
- New establishment in Beersel. KBO
In short
From € 2.7 million profit in 2022 to € 5.4 million profit in 2025.
Paid € 5.5 million in corporate taxes since 2022.
Best year ever: 2025, with € 5.4 million profit.
Paid out € 15 million in dividends to the owners in total.
A new publication or filing at COLOPLAST BELGIUM? We notify you, reason included.
Follow COLOPLAST BELGIUMDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The shares are held by Coloplast A/S (100%).
Directors
According to the 2025 annual accounts
Anton Malling Mikkelsen
Director
since 2023 · until 2029
Henrik Deneke
Director
since 2023 · until 2029
Henning Reichardt
Director
since 2023 · until 2029
Shareholders
Coloplast A/S
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Guido Gezellestraat 121
1654 Beersel
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0423.051.642
- VAT number
- BE 0423.051.642
- Registered office
- Guido Gezellestraat 121, 1654 Beersel
- Names & denominations
- COLOPLAST BELGIUM
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 16 November 1982
- Peppol
- Active · Active since 5 Nov 2025
- Activities · NACE
Groothandel in farmaceutische producten
Groothandel in farmaceutische en medische artikelen